The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
Published
Journal Article
Malignant pleural mesothelioma (MPM) is an uncommon and usually fatal primary neoplasm of the pleura. In the past, response to standard therapy has been poor [1-3], but recent studies suggest that some patients may benefit from various therapeutic options, including surgical resection, combined technique treatment, and immunotherapy [4-7]. With improvements in therapy, an accurate, widely accepted staging system will be important in selecting homogeneous groups of patients for entry into clinical trials. Multiple staging systems have previously been proposed for MPM, but none are universally used [8].
Full Text
Duke Authors
Cited Authors
- Patz, EF; Rusch, VW; Heelan, R
Published Date
- February 1996
Published In
Volume / Issue
- 166 / 2
Start / End Page
- 323 - 327
PubMed ID
- 8553940
Pubmed Central ID
- 8553940
International Standard Serial Number (ISSN)
- 0361-803X
Digital Object Identifier (DOI)
- 10.2214/ajr.166.2.8553940
Language
- eng
Conference Location
- United States